Previous 10 | Next 10 |
home / stock / morf / morf articles
SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ:MORF) to d...
SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ:MORF) to d...
SAN DIEGO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding, Inc. (NASDAQ:...
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Por...
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Mo...
SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Mo...
SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Mo...
SAN DIEGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securiti...
WALTHAM, Mass., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biopharmaceutical company developing a new generation of ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:15:05 ET RBC Capital analyst issues SECTOR PERFORM recommendation for MORF on July 9, 2024 06:29AM ET. The previous analyst recommendation was Outperform. MORF was trading at $55.74 at issue of the analyst recommendation. The overall analyst consensus : BUY...
2024-07-08 20:00:07 ET Edward Nash from Canaccord Genuity issued a price target of $57.00 for MORF on 2024-07-08 18:49:00. The adjusted price target was set to $57.00. At the time of the announcement, MORF was trading at $55.74. The overall price target consensus is at $...